Skip to main content

Eshelman Innovation, Eshelman School of Pharmacy, Lineberger Comprehensive Cancer Center, and UNC School of Medicine have come together to build upon UNC’s world class drug discovery infrastructure, expand its capabilities through external partnerships, and fund promising UNC therapeutic programs. The ultimate goal is to help advance such programs further down the translational path and maximize the chances of reaching patients with novel treatments while realizing value for UNC and its researchers.


The Drug Discovery Initiative Joint Steering Committee

The Drug Discovery Initiative is lead by a Joint Steering Committee (JSC) of UNC’s leadership in health sciences. The JSC manages and works to accomplish the mission of the Drug Discovery Initiative by making project funding decisions, infrastructure allocation, management fee determinations, and defining scientific focus.


John Bamforth, PhD

Executive Director, Eshelman Innovation


Blossom Damania, PhD

Boshamer Distinguished Professor
Vice Dean for Research, UNC School of Medicine


Shelley Earp, MD

Distinguished Professor, Lineberger Professor of Cancer Research
Director, UNC Lineberger Comprehensive Cancer Center


Stephen Frye, PhD

Fred Eshelman Distinguished Professor
Co-Director, Center for Integrative Chemical Biology and Drug Discovery


Angela Kashuba, BScPhm, PharmD, DABCP, FCP

John A. and Margaret P. McNeill, Sr. Distinguished Professor
Dean, UNC Eshelman School of Pharmacy

Penny Gordon-Larsen, PhD

Carla Smith Chamblee Distinguished Professor of Global Nutrition
Interim Vice Chancellor for Research, University of North Carolina – Chapel Hill